Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
of Riccardo Catena at Chalmers University. The overall goal of the project is to develop, numerically implement, and apply a theoretical framework to accurately describe the expected dark matter-induced
-
Development of Machine Learning for Molecular Applications – Molecular Machine Learning” (SPP 2363 ) and will involve tight collaboration with the group of Prof. Dr. Frank Glorius from the University of Münster
-
). For recruitment services the GTC of ETH Zurich apply. About ETH Zürich ETH Zurich is one of the world’s leading universities specialising in science and technology. We are renowned for our excellent education
-
exhaled breath. The project will be conducted in collaboration with Agroscope (Liebefeld Campus), University Hospital Zurich, and the Swiss Allergy Centre (aha!). The position will last for one year, with
-
the position should be directed to Prof. Ueli Angst or Dr. Zhidong Zhang by email (for contact details, please see website indicated above). ETH Zurich is one of the world’s leading universities specialising in
-
. This position is part of a collaborative project funded by the Swiss National Science Foundation, which supports multiple researchers, at ETH Zurich and at partner universities, and focuses on the development
-
. Empa is a research institution of the ETH Domain. Our Structural Engineering Research Laboratory developed new materials, systems, and manufacturing techniques for civil infrastructure use. It is one
-
encourages excellence, individual recognition and responsibility. The Faculty of Biology and Medicine (FBM ) of the University of Lausanne is inviting applications for a position of: Tenure Track Assistant
-
fully funded, full-time PhD position focused on the development of novel thermochemical approaches for the production of green hydrogen. The position is expected to start on 1 August 2025
-
they need today and for generations to come. Creating a world where we all have more time with the people we love. That’s what makes us Roche. In Roche’s Pharmaceutical Research and Early Development